DK0538897T3 - Anvendelse af BMY 14802 ved behandling af angst hos benzodiazepinseponerede patienter - Google Patents

Anvendelse af BMY 14802 ved behandling af angst hos benzodiazepinseponerede patienter

Info

Publication number
DK0538897T3
DK0538897T3 DK92118219.2T DK92118219T DK0538897T3 DK 0538897 T3 DK0538897 T3 DK 0538897T3 DK 92118219 T DK92118219 T DK 92118219T DK 0538897 T3 DK0538897 T3 DK 0538897T3
Authority
DK
Denmark
Prior art keywords
treatment
bmy
benzodiazepine
anxiety
exposed patients
Prior art date
Application number
DK92118219.2T
Other languages
Danish (da)
English (en)
Inventor
Herbert L Smith
Frank D Yocca
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK0538897T3 publication Critical patent/DK0538897T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK92118219.2T 1991-10-24 1992-10-23 Anvendelse af BMY 14802 ved behandling af angst hos benzodiazepinseponerede patienter DK0538897T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78201091A 1991-10-24 1991-10-24

Publications (1)

Publication Number Publication Date
DK0538897T3 true DK0538897T3 (da) 1997-08-25

Family

ID=25124656

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92118219.2T DK0538897T3 (da) 1991-10-24 1992-10-23 Anvendelse af BMY 14802 ved behandling af angst hos benzodiazepinseponerede patienter

Country Status (18)

Country Link
US (1) US5278164A (ko)
EP (1) EP0538897B1 (ko)
JP (1) JPH05238934A (ko)
KR (1) KR100196334B1 (ko)
AT (1) ATE150645T1 (ko)
AU (1) AU649169B2 (ko)
CA (1) CA2081062A1 (ko)
CY (1) CY2019A (ko)
DE (1) DE69218544T2 (ko)
DK (1) DK0538897T3 (ko)
ES (1) ES2101000T3 (ko)
GR (1) GR3022945T3 (ko)
HK (1) HK113897A (ko)
IL (1) IL103499A0 (ko)
OA (1) OA09766A (ko)
PH (1) PH30028A (ko)
TW (1) TW217382B (ko)
ZA (1) ZA928105B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011091418A1 (en) * 2010-01-25 2011-07-28 Northeastern University Screening method for adverse side effects of a therapeutic pharmaceutical drug

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605655A (en) * 1984-03-06 1986-08-12 Bristol-Myers Company Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
US5055470A (en) * 1989-06-01 1991-10-08 Bristol-Myers Squibb Co. Method of treatment of ischemia in brain

Also Published As

Publication number Publication date
KR930007452A (ko) 1993-05-20
AU649169B2 (en) 1994-05-12
CA2081062A1 (en) 1993-04-25
US5278164A (en) 1994-01-11
GR3022945T3 (en) 1997-06-30
DE69218544D1 (de) 1997-04-30
DE69218544T2 (de) 1997-11-13
CY2019A (en) 1998-02-20
EP0538897A1 (en) 1993-04-28
HK113897A (en) 1997-08-29
PH30028A (en) 1996-11-08
EP0538897B1 (en) 1997-03-26
ES2101000T3 (es) 1997-07-01
ZA928105B (en) 1993-08-25
TW217382B (ko) 1993-12-11
KR100196334B1 (ko) 1999-06-15
IL103499A0 (en) 1993-03-15
AU2716592A (en) 1993-04-29
JPH05238934A (ja) 1993-09-17
ATE150645T1 (de) 1997-04-15
OA09766A (en) 1993-11-30

Similar Documents

Publication Publication Date Title
HU9300636D0 (en) Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
DE69019716D1 (de) Medizinisches Gerät zur Laserbehandlung.
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
DK0499923T3 (da) Dentaladhæsiv
ATE120954T1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines arzneimittels zur behandlung von aids.
DK0998287T3 (da) Anvendelse af levobupivacain
ATE191849T1 (de) Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
DK0652000T3 (da) Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et lægemiddel til inhibering af angiogenese og angiogene sygdomme
DK0981347T3 (da) Anvendelsen af levobupivacain i ansigtkirurgi
DK0655243T3 (da) Melatoninderivater til anvendelse ved behandling af søvnlidelser
DK0476113T3 (da) Lægemiddel til behandling af hyperlipidæmi og/eller atherosklerose
DK0538897T3 (da) Anvendelse af BMY 14802 ved behandling af angst hos benzodiazepinseponerede patienter
DE69511453T2 (de) Verwendung einer Kombination von Antineoplastonen zur Herstellung eines Arzneimittels zur Behandlung der Neurofibromatose
ATE147978T1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
SE9101341D0 (sv) New medicinal use
DE69228235T2 (de) Verwendung eines Mittels zur Herstellung eines Arzneimittels zur Behandlung von Lebererkrankung
SE9403861D0 (sv) Novel medicinal use
EE200100122A (et) R-(+)-alfa-(2,3-dimetoksüfenüül)-1-[2-(4-fluorofenüül)etüül]-4-piperidiinmetanooli kasutamine unehäirete raviks
FR2701213B3 (fr) Canule d'injection pour traitements médicaux.
ES1019006Y (es) Jeringa de anestesia dental desechable.
DK0495721T3 (da) Anvendelsen af et polypeptid med en humant-interleukin-2-aktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af pneumothorax
IT9048106A0 (it) Associazione medicamentosa per il trattamento dell'ipertensione e dell'insufficienza cardiaca congestiva. (caso 100-7516)
ITPD940223A0 (it) Cannula per trattamento clinico-chirurgico del pannicolo adiposo